Next Article in Journal
Drug Combination in Cancer Treatment—From Cocktails to Conjugated Combinations
Next Article in Special Issue
The Prognostic Value of the New Combined Hemo-Eosinophil Inflammation Index (HEI Index): A Multicenter Analysis of Anal Cancer Patients Treated with Concurrent Chemo-Radiation
Previous Article in Journal
Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant Tumors
Previous Article in Special Issue
Rectal Dose Is the Other Dosimetric Factor in Addition to Small Bowel for Prediction of Acute Diarrhea during Postoperative Whole-Pelvic Intensity-Modulated Radiotherapy in Gynecologic Patients
Article

Feasibility and Safety of Repeated Carbon Ion Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer

1
Gunma University Heavy-ion Medical Center, Gunma University Graduate School of Medicine, Gunma 371-0811, Japan
2
Japanese Red Cross Maebashi Hospital, Gunma 371-0811, Japan
*
Author to whom correspondence should be addressed.
Academic Editors: Meritxell Arenas and Pierfrancesco Franco
Cancers 2021, 13(4), 665; https://doi.org/10.3390/cancers13040665
Received: 6 January 2021 / Revised: 1 February 2021 / Accepted: 3 February 2021 / Published: 7 February 2021
(This article belongs to the Special Issue Cancer Radiotherapy)
Despite the effectiveness of carbon ion radiotherapy (CIRT) for locally advanced unresectable pancreatic cancer (URPC), isolated local recurrence after CIRT is a therapeutic challenge. Herein, we aimed to evaluate the feasibility and safety of a second course of CIRT for locally recurrent URPC in 10 patients. One patient developed grade 3 diarrhea immediately after the second CIRT; no other grade 3 or higher adverse events were induced by CIRT. The estimated 1-year overall survival rate and local control rate after the second CIRT were 48% and 67%, respectively. Repeated CIRT is feasible with acceptable toxicity for selected patients with locally advanced URPC after CIRT.
Purpose: The feasibility and safety of re-irradiation with carbon ion beams for locally recurrent unresectable pancreatic cancer (URPC) after carbon ion radiotherapy (CIRT) was evaluated. Methods: Medical records from patients with re-irradiated URPC who were treated with CIRT between November 2017 and February 2019 were reviewed. Inclusion criteria were (1) isolated local recurrence after CIRT, (2) URPC, and (3) tumor located at least 3 mm from the gastrointestinal tract. The first and second CIRT irradiation doses were 55.2 Gy (relative biological effectiveness) in 12 fractions. Results: Ten patients met the inclusion criteria. The median follow-up period was 25.5 months (range, 16.0–69.1) after the first CIRT and 8.9 months (range, 6.4–18.9) after the second CIRT. The median interval between the initial CIRT and the local recurrence was 15.8 months (range, 8.0–50.1). One patient developed grade 3 diarrhea immediately after the second CIRT; no other grade 3 or higher adverse events were attributed to CIRT. The estimated 1-year overall survival, local control, and progression-free survival rates after the second CIRT were 48%, 67%, and 34%, respectively. Conclusion: Repeated CIRT is feasible with acceptable toxicity for selected patients with locally advanced URPC after CIRT. View Full-Text
Keywords: carbon ion radiotherapy; pancreatic cancer; local recurrence; re-irradiation; locally advanced pancreatic cancer carbon ion radiotherapy; pancreatic cancer; local recurrence; re-irradiation; locally advanced pancreatic cancer
Show Figures

Figure 1

MDPI and ACS Style

Okamoto, M.; Shiba, S.; Okazaki, S.; Miyasaka, Y.; Shibuya, K.; Kiyohara, H.; Ohno, T. Feasibility and Safety of Repeated Carbon Ion Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer. Cancers 2021, 13, 665. https://doi.org/10.3390/cancers13040665

AMA Style

Okamoto M, Shiba S, Okazaki S, Miyasaka Y, Shibuya K, Kiyohara H, Ohno T. Feasibility and Safety of Repeated Carbon Ion Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer. Cancers. 2021; 13(4):665. https://doi.org/10.3390/cancers13040665

Chicago/Turabian Style

Okamoto, Masahiko, Shintaro Shiba, Shohei Okazaki, Yuhei Miyasaka, Kei Shibuya, Hiroki Kiyohara, and Tatsuya Ohno. 2021. "Feasibility and Safety of Repeated Carbon Ion Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer" Cancers 13, no. 4: 665. https://doi.org/10.3390/cancers13040665

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop